This study describes 24 h profiles of growth hormone (GH) and of cortisol in male and female prepubertal calves before, during and after treatment with estradiol-17β (E2, silastic implants, 45 mg). Plasma concentrations of estradiol, testosterone and of insulin-like growth factor-1 (IGF-1) were also recorded. No significant (P<0.05) sex differences in GH, IGF-1 and in cortisol secretion were observed in untreated animals before E2-treatment. GH means, baselines and peak amplitudes increased during the treatment and remained elevated 1 week after removal of E2 in female calves, but were unchanged in male calves. In contrast, IGF-1 plasma concentrations were increased in both sexes during and after E2-treatment. In males maximal IGF-1 concentrations were higher than in females. Cortisol profiles showed a high individual variability and no consistant changes related to sex or E2-stimulation. Based on the observation that the male calves already had a significant testosterone secretion, we conclude that the observed sex differences of GH-secretion in response to E2 are related to endogenous testosterone. The E2-stimulated increase of IGF-1 plasma concentrations in males appears as related to an altered GH responsiveness rather than to changes in GH secretory patterns.
No takes yet. Share an insight, caveat, or question.
Sauerwein et al. (1992) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: